Results
Akums Q2 Revenue Up 32% YoY, PAT Surges 168%
Akums Drugs disclosed its Q2 FY27 investor presentation for a conference call, reporting a 31.9% YoY revenue growth to ₹1,342 crore.
Consolidated PAT surged 168.3% YoY to ₹115 crore, driven by a 106.1
